FCCC LOGO Faculty Publications
Small W , Mell LK , Anderson P , Creutzberg C , De Los Santos J , Gaffney D , Jhingran A , Portelance L , Schefter T , Iyer R , Varia M , Winter K , Mundt AJ
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer
International Journal of Radiation Oncology Biology Physics. 2008 Jun;71(2) :428-434
PMID: ISI:000255971100018   
Back to previous list
Purpose: To develop an atlas of the clinical target volume (CTV) definitions for postoperative radiotherapy of endometrial and cervical cancer to be used for planning pelvic intensity-modulated radiotherapy. Methods and Materials: The Radiation Therapy Oncology Group led an international collaberation of cooperative groups in the development of the atlas. The groups included the Radiation Therapy Oncology Group, Gynecologic Oncology Group, National Cancer Institute of Canada, European Society of Therapeutic Radiology and Oncology, and American College of Radiology Imaging Network. The members of the group were asked by questionnaire to define the areas that were to be included in the CTV and to outline theses areas on individual computed tomography images. The initial formulation of the group began in late 2004 and culminated with a formal consensus conference in June 2005. Results: The committee achieved a consensus CTV definition for postoperative therapy for endometrial. and cervical cancer. The CTV should include the common, external, and internal iliac lymph node regions. The upper 3.0 cm of the vagina and paravaginal soft tissue lateral to the vagina should also be included. For patients with cervical cancer, or endometrial cancer with cervical stromal invasion, it is also recommended that the CTV include the presacral lymph node region. Conclusion: This report serves as an international template for the definition of the CTV for postoperative intensity-modulated radiotherapy for endometrial and cervical cancer. (c) 2008 Elsevier Inc.
ISI Document Delivery No.: 302LZ Times Cited: 0 Cited Reference Count: 35 Cited References: AHAMAD A, 2005, INT J RADIAT ONCOL, V62, P1117 AYDOGAN B, 2007, INT J RADIAT ONCOL S, V69, S401 BERGMAN RA, 1991, ATLAS HUMAN ANATOMY, P274 BERIWAL S, 2006, GYNECOL ONCOL, V102, P195 BERIWAL S, 2006, INT J RADIAT ONCOL, V64, P1395 BERIWAL S, 2007, INT J RADIAT ONCOL, V68, P166 BO WJ, 2007, BASIC ATLAS SECTIONA, P313 BONIN SR, 1996, INT J RADIAT ONCOL, V34, P167 BRIXEY CJ, 2002, INT J RADIAT ONCOL, V54, P1388 CHAO KSC, 2002, INT J RADIAT ONCOL, V54, P1147 ELLIS H, 1991, HUMAN CROSS SECTIONA, P346 FINLAY MH, 2006, INT J RADIAT ONCOL, V64, P205 HALL EJ, 2006, INT J RADIAT ONCOL, V65, P1 HERON DE, 2003, GYNECOL ONCOL, V91, P39 KIM RY, 1995, INT J RADIAT ONCOL, V31, P109 KNAB BR, 2004, INT J RADIAT ONCOL S, V60, S303 KOCHANSKI JD, 2006, CLIN ADV HEMATOL ONC, V4, P379 LUJAN AE, 2003, INT J RADIAT ONCOL, V57, P516 MARNITZ S, 2006, STRAHLENTHER ONKOL, V182, P80 MELL LK, 2005, CANCER, V104, P1296 MELL LK, 2006, INT J RADIAT ONCOL, V66, P1356 MOORE CJ, 2006, BRIT J RADIOL, V79, S66 MORROW CP, 1996, GYNECOLOGIC CANC SUR, P451 MUNDT AJ, 2002, INT J RADIAT ONCOL, V52, P1330 MUNDT AJ, 2003, INT J RADIAT ONCOL, V56, P1354 PORTELANCE L, 2001, INT J RADIAT ONCOL, V51, P261 RANDALL ME, 2006, SEMIN RADIAT ONCOL, V16, P138 RICHTER E, 2004, NORMAL LYMPH NODE TO, P113 ROESKE JC, 2000, INT J RADIAT ONCOL, V48, P1613 SALAMA JK, 2006, INT J RADIAT ONCOL, V65, P1170 SMALL W, 2006, CONSENSUS GUIDELINES TAYLOR A, 2005, INT J RADIAT ONCOL, V63, P1604 VANDENBERG HA, 2000, RADIOTHER ONCOL, V54, P163 WHEELESS CR, 1997, ATLAS PELVIC SURG, P423 WONG E, 2005, INT J RADIAT ONCOL, V61, P830 Small, William, Jr. Mell, Loren K. Anderson, Penny Creutzberg, Carien De Los Santos, Jennifer Gaffney, David Jhingran, Anuja Portelance, Lorraine Schefter, Tracey Iyer, Revathy Varia, Mahesh Winter, Kathryn Mundt, Arno J. ELSEVIER SCIENCE INC; 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA